Rx Propellant Private Limited - Company Profile

Q: Who are the current directors of Rx Propellant Private Limited?

The current directors of Rx Propellant Private Limited are Praveen Kumar Poonamallee Sridharan, Mohammed Hameeduddin Farouqui, Richard Stephen Mully, Dinesh Meel, Raghvendra Chandak, Sandhya Rani Sama, Ashish Balram Singh, Brian David Chinappi, Ashish Balram Singh.

It is a life sciences private limited company based in Shaikpet, Telangana, India, established in 2020.

2020 Shaikpet, Telangana, India Active

Last Updated: February 06, 2026

Access Report

About Rx Propellant Private Limited

Rx Propellant Private Limited, a active private limited company, was established on 23 October 2020 in Shaikpet, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U70109TG2020PTC145191. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹240.01 Cr and a paid-up capital of ₹131.01 Cr.

Formerly known as Rx Propellant Asset Advisors Private Limited. It upholds a compliant status. Employing 24 professional, Its leadership includes Praveen Kumar Poonamallee Sridharan (Director), Richard Stephen Mully (Director), Dinesh Meel (Director). Past directors included Praveen Kumar Poonamallee Sridharan, Richard Stephen Mully, Dinesh Meel. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No 505A, 5Th Floor, Gowra Palladium, Plot No 8A And 8B/1,, Raidurg Village, Serlingampally Mandal,Ranga Reddy District,, Shaikpet, Telangana, 500081.

Company Details

CIN/LLPIN
U70109TG2020PTC145191
Registration Number
145191
Incorporation Date
23 October 2020
Authorized Capital
₹240.01 Cr
Paid-Up Capital
₹131.01 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 240.01 Cr as on 06-02-2026
Paid Up Capital ₹ 131.01 Cr as on 06-02-2026
Company Age 5 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** % (FY 2023)
Profit Growth **** -61900.73% (FY 2023)
Ebitda **** -71094.20% (FY 2023)
Net Worth 117903.27% (FY 2023)
Total Assets **** 226694.73% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Rx Propellant Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Rx Propellant Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Praveen Kumar Poonamallee Sridharan	Director	11 May 2022	Current
Richard Stephen Mully	Director	29 Jul 2022	Current
Dinesh Meel	Director	07 May 2024	Current
Raghvendra Chandak	Director	11 May 2022	Current
Ashish Balram Singh	Ceo	22 Oct 2025	Current
Brian David Chinappi	Director	08 Nov 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	11 May 2022	Past
Pramod Abcsdd	Additional Director	28 Sep 2022	Past
Pramod Abcsdd	Additional Director	12 Sep 2024	Past
Pramod Abcsdd	Additional Director	11 May 2022	Past
Pramod Abcsdd	Director	11 May 2022	Past
Pramod Abcsdd	Additional Director	11 May 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rx Propellant.

Rx Propellant Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 61900.73% decrease in profit. The company's net worth Soared by an impressive increase of 117903.27%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

226694.73%

*******

Profit or Loss

*******

-61900.73%

*******

Net Worth

*******

117903.27%

*******

EBITDA

*******

-71094.20%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rx Propellant?

In 2023, Rx Propellant had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rx Propellant?

Rx Propellant has a workforce of 24 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rx Propellant, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx Propellant's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rx Propellant

Recent Activity within the Organization

Director Appointment

Ashish Balram Singh was appointed as a Ceo was appointed as a Ceo on 24 Oct 2025 & has been associated with this company since 3 months 18 days . was recorded as a recent event.
24 Oct 2025
Director Appointment

Ashish Balram Singh was appointed as a CEO was appointed as a CEO on 22 Oct 2025 & has been associated with this company since 3 months 20 days . was recorded as a recent event.
22 Oct 2025
Annual General Meeting

The activity Rx Propellant Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

The activity Rx Propellant Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

Dinesh Meel was appointed as a Director was appointed as a Director on 07 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
07 May 2024
Director Appointment

Brian David Chinappi was appointed as a Director was appointed as a Director on 08 Nov 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.
08 Nov 2023

Explore recent activity and updates - View Recent Activity